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OBJECTIVES: Diabetes has been increasing worldwide and the treatment of type 2
diabetes is based on lifestylemodification and pharmacological therapy. Appropri-
ate self-care practices including lifestylemodifications andmedication compliance
are critical to satisfactory control andmanage diabetes and to prevent from comor-
bidities. The objective of this studywas to assess current treatment patterns, treat-
ment compliance and reasons for noncompliance for patients with type 2 diabetes
in Pakistan. METHODS: A cross-sectional study was conducted to collect data
through structured interviews based on pre-tested questionnaire. Total 211 pa-
tients including 46% males and 54% females from the ages 25 and over were ran-
domly selected for the study fromapopulation of patients attending 5 primary care
diabetes centers throughout Karachi. Information was collected on socio-demo-
graphic characteristics, diabetes duration and compliance to physician’s advices.
RESULTS: Overall, median age for male subjects was 53 years, significantly older
(p0.008) than females (46 years). The mean duration of diabetes among respon-
dents was 9.23.8 years. Of the total, majority of patients were treated with oral
medication (61%). Only 27% reported full compliance as per physician’s advice for
timelymedication, routine exercise, timely lab investigation and follow up for next
visit. About 45% of the subjects were taking medication for diabetes related com-
plications. Lack of financial resources, knowledge and supportive services and fear
of needle were the main reasons for noncompliance. We also found that people
with low literacy levels were less likely to manage their condition effectively com-
pared to people with higher educational level (p0.001). CONCLUSIONS: To man-
age the diabetes both physicians and patients should attempt to improve compli-
ance, which could lead to better disease management. Based on the findings, a
public health intervention and information campaign is needed to change behav-
iours of persons with diabetes. Further, physicians can also educate patients by
identifying potential risks of non-compliance and educate them accordingly.
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OBJECTIVES: To quantify the influence of methodological assumptions/parame-
ters on the results of prescription-based NA analysis based on 3-years prescription
data (German Statutory Health Insurance Fund) covering 241,537 T2DM patients.
METHODS: With the help of MPRs in an interval-based approach, a NA-base sce-
nario for 25 anti-diabetic active ingredients was calculated for each patient. In a
scenario analysis, the quantitative influence of all in all 9 parameters on the MPR
level was derived. The most important parameter concerned the definition of an
ideal prescription profile (“100%-adherer”). Assumptions simplifying the real pre-
scription behaviour did not allow to accurately reflect the variety of medications
and the clinical need to change medications. Therefore, a total of eight clinically
meaningful prescription profileswere derived assigning patients exclusively by the
use of self-developed algorithms. For each patient a MPR estimated by standard
methodology (base case)was comparedwith theMPR based on our novel approach.
RESULTS: In the base case, the average MPR resulting from the analysed active
ingredient combinations was 80.76%. A total of 62.85% of patients had an
MPR80%. According to the novel prescription profiles, patients were distrib-
uted as follows: 59.9% Mono-medication, 12.9% Single-Drug Switcher, 11.3%
Single-Drug Add-on, 2.0% Multiple-Drug Add-on, 5.0% Polytherapy consistent,
2.5% Polytherapy Add-on, 3.5% Polytherapy Drop-off, and 1.3% Polytherapy
Switcher. A total of 1.6% of the patients could not unequivocally be assigned to
one of the categories. Comparing a base-case MPR analysis with our novel ap-
proach resulted in MPR deviations in specific patient groups of up to 27.4 per-
centage points. CONCLUSIONS: Probably the biggest challenge in NA analysis
based on prescription data is to differentiate between physician-induced and pa-
tient-induced medication changes. The first should be reflected in the adequate
profile of an NA analysis and should not be misinterpreted as NA itself. The meth-
odology described presents a powerful alternative for defining clinically meaning-
ful prescription patterns.
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OBJECTIVES: The burden of diabetic peripheral neuropathic pain (DPNP) on pa-
tients’ lives is poorly understood and insufficiently measured with current instru-
ments. Proper assessment of DPNP impact on patients’ lives is critical to accurately
determine treatment efficacy. METHODS: 45 blinded, semi-structured telephone
interviews were conducted to assess the impact of DPNP on functioning and pa-
tient well-being enrolled in a randomized, double-blind, placebo-controlled study.
Interviews were taped, transcribed, coded, and analyzed according to grounded
theory principles. RESULTS: Patients were 31%female, 53% white and the average
agewas 56 years. Twomajor domains of burdenwere identified: physical function-
ing and daily life. Physical functioning was affected in 36 (80%) patients whose
DPNP led to difficulty in walking, 33 (73%) reported low energy levels, and 32 (71%)
noted a diminished ability to exercise. Twenty-five (55%) patients reported difficul-
ties with bending, 22 (49%) difficulty standing, 20 (44%) reduced ease of movement,
19 (42%) had problems with balance and 16 (36%) in climbing stairs. DPNP affected
sleep in 37 (82%) patients who reported awakening in the night, 28 (62%) had diffi-
culty falling asleep, 16 (36%) couldn’t fall back asleep once awakened; and 36 (80%)
patients rarely felt rested during the day. Daily life was affected in 34 (76%) patients
leading to reduced productivity, 30 (67%) reported that DPNP reduced their enjoy-
ment of life, and 26 (58%) found that DPNP limited their recreational activities.
Twenty-four (53%) of patients had a reduced ability to focus on tasks due to pain, 22
(49%) reported that DPNP limited their ability to work, 20 (44%) experienced diffi-
culty in accomplishing routine household chores, and 17 (38%) had reduced
independence. CONCLUSIONS: DPNP causes significant burden on patient’s phys-
ical functioning and daily life. PROmeasures used to determine treatment efficacy
should assess these impacts to accurately reflect the patient’s perspective.
PDB46
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OBJECTIVES: Diabetic Peripheral Neuropathic Pain (DPNP) is a poorly understood
complication of diabetes that has serious consequences for patients’ physical func-
tioning and daily activities. Awell-developed patient-reported outcome (PRO)mea-
sure that can assess the impact of DPNP on function and that is sensitive to change
would facilitate research important to patients. The purpose of the study was to
develop a measure of key impacts important to patients with DPNP. METHODS:
Diabetic Peripheral Neuropathic Pain (DPNP) is a poorly understood complication of
diabetes that has serious consequences for patients’ physical functioning and daily
activities. A well-developed patient-reported outcome (PRO) measure that can as-
sess the impact of DPNP on function and that is sensitive to changewould facilitate
research important to patients. The purpose of the studywas to develop ameasure
of key impacts important to patients with DPNP. RESULTS: Saturation of concepts
was reached after 3 focus groups and telephone interviews with a total of 25 DPNP
patients (demographics: average age 52 years old, 68% male, 60% White). The av-
erage duration of DPNPwas 5 years (range 1-20 years) and the average self-reported
pain score (scale 0-10) was 6.9 (range 4-10). The theoretical framework described
two domains of impact: Physical Functioning and Daily Functioning. Based on the
results of the cognitive debriefing a 27-item, validation ready version of the mea-
sure with 4 domains (Physical Functioning–Sleep, Physical Functioning-Mobility,
Daily Functioning- Daily Activities and Daily Functioning-Relationships) was
generated. CONCLUSIONS: The Diabetic Peripheral Neuropathic Pain Impact Mea-
sure is believed to accurately capture relevant DPNP patients’ experiences as it
relates to their ability to function. Data generated from the measure should assist
clinicians in assessing key impacts in patientswithDPNP, facilitate development of
targeted treatments and provide a meaningful measurement of treatment effect.
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OBJECTIVES: Lack of access to healthcare for patients with diabetes has been as-
sociatedwith lower self-reported health-related quality of life (HRQOL), whichmay
lead to significant economic burden. The objective of the study was to determine
the impact of healthcare access on HRQOL of patients with diabetes. METHODS:
The 2009 Behavioral Risk Factor Surveillance System (BRFSS), a national health
telephone survey administered by the Centers for Disease Control and Prevention
(CDC), was analyzed. It included questions on patient demographics and health-
related perceptions, conditions, and behaviors. HRQOL was defined as the number
of unhealthy days, a sum of physical and mental unhealthy days in the past one
month. Healthcare access was defined by whether the patient had healthcare cov-
erage, had a healthcare professional or could not see a doctor because of cost.
Descriptive analysis includedmeans, standard errors and relevant T-tests. Poisson
regression was performed to measure the impact of healthcare access variables,
age, race, gender,marital status andmedian household income onunhealthy days.
RESULTS: In 2009, from 5.2 million diabetic patients, 0.7 million (14%) did not have
healthcare coverage, 0.48 million (9%) did not have healthcare professional and
1.54 million (30%) could not see a doctor due to cost. The average number of un-
healthy days in a month, for diabetic patients with healthcare coverage was lower
than those without (22 days versus 23 days, p-value0.01); for those who could see
a doctor due to cost was lower than those who could not (22 days versus 24 days,
p0.01); was the same for those with or without a healthcare professional. Regres-
sion results showed, not having healthcare coverage and healthcare professional,
each significantly (p-value0.01) increased an excess unhealthy day in diabetic
patients. CONCLUSIONS: Lack of healthcare access negatively impacts HRQOL.
Measures are needed to ensure adequate healthcare access in diabetic patients.
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OBJECTIVES: To assess the quality of life (QoL) of Taiwanese type 2 diabetes pa-
tients, we have conducted feasibility studies applying different QoL utility scores.
This study aims to explore the adaptation and feasibility of time-trade-off (TTO)
method for measuring QoL in Taiwanese diabetic outpatients. METHODS: This
cross-sectional study was conducted from June to December 2010 at nephrology
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clinics of a regional hospital in southern Taiwan. Outpatients with type 2 diabetes
were invited to participate the interviews for measuring QoL. After finishing the
TTO exercise for measuring QoL, a semi-structured interview was followed to ex-
plore participant’s view on themethods and specific attributes for trading off. TTO
results were transformed to utility value, and interviews were recorded, tran-
scribed verbatim and analyzed by constant comparison approach to saturation.
RESULTS:Of all, 96 of the 100 participants completed the TTO (mean age: 55.811.0
years, 54.2% male) the average utility is 0.6920.217, yet most participants (n68,
70.8%) accepted current health status and life expectancy and were reluctant to
give up any life years to exchange a full health. At interviews, participants revealed
their worries, anxiety, discomfort and disturbances of daily life related to diabetes,
but those factors were not considered when trading life year and health status
during TTO exercise; instead, satisfaction of life expectancy, child-caring and self-
recognition on values of life were considered. Information provided by healthcare
providers, peer supports and religions were found to help patients cope with the
disease and improve health-related QoL. CONCLUSIONS: For patients with
chronic, stable diabetes, an adaptation process may have diluted the impacts of
patients’ concerns on health-related QoL, and hence trading on life years and
health status is inappropriate to measure QoL utility. Further study is to explore
feasibility of TTO at different stages of diabetic complications, and cross-validate
between TTO and other utility measures.
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OBJECTIVES: Quality-of-life (QoL) is increasingly recognized as an important out-
comemeasure that provides information on the burden of diabetes on the physical,
mental and social aspects of patients’ health. To pick up disease-related changes in
QoL of diabetes patients in Korea, we administered Korean Audit of Diabetes-
Dependent Quality-of-Life (KR-ADDQoL) instrument. METHODS: A prospective,
observational study was carried out on type 2 diabetic patients from the diabetic
clinics of 24medical centers throughout Korea. A total of 413 diabetic patients aged
40 years and over were assessed for Health-Related QoL (HRQoL). HRQoL was as-
sessedwith KR-ADDQoL instrument. RESULTS: Patients with diabetes were 589.7
years old (47.2% female), had diabetes for 7.06.2 years. Themean present QoLwas
0.40.97 (range: 3 [extremely bad] to 3 [excellent]) and diabetes-dependent QoL
was 1.50.98 (range: 3 [very much better] to 1 [worse]). Patients with diabetes
and those with hypertension reported lower present QoL, compared with diabetes
only (0.31.01, 0.60.85; p0.0161). The mean KR-ADDQoL average weighted im-
pact (AWI) score was 2.41.8. Patients with 15-20 years of diabetes reported sig-
nificantly worse AWI scores (3.71.6) compared with those with 10-15 years
(1.91.5). A negative impact of diabetes was seen in all the dimensions of KR-
ADDQoL. Freedom to eat and people’s reaction remained as the most (mean AWI
scores: 4.32.8) and least (1.32.1) affected QoL domains, respectively, when
weighting was considered. CONCLUSIONS: Type 2 diabetes has a negative impact
in HRQoL in the patients studied. The findings highlighted the impact of diabetes
on QoL with particular reference to the effects on freedom to eat, and freedom to
drink. Our study contributed to the knowledge of QoL in Korean patients with type
2 diabetes by using a diabetes-specific QoL instrument. These findings suggest that
the impact of diabetes in QoL among Asian is similar [ADDQoL AWI score in Sin-
gaporeans: 2.61.9].
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OBJECTIVES: We assessed medication beliefs and evaluated association between
race andmedication beliefs among low-incomeAfricanAmericans andCaucasians
with diabetes. METHODS: A cross-sectional self-administered written survey of
Type 2 diabetes patients was conducted at a primary-care clinic affiliated with a
hospital serving an urban population. Inclusion criteria were being 18 years or
older, diagnosed with Type 2 diabetes at least 6 months prior to the time of the
survey, and taking oral anti-diabetic medication. Exclusion criteria were use of
insulin or inability to read and write in English. The survey included the Beliefs
about Medications Questionnaire to assess individuals’ medication beliefs. Analy-
sis of variance was used to compare differences in medication beliefs across race.
RESULTS: Usable responses were obtained from 236 of 397 individuals who satis-
fied inclusion and exclusion criteria, for a response rate of 59%. The sample was
53% African American, 47% Caucasian, 63% female and 72% had annual household
income of less than $25,000. A majority (63%) had at most completed high school
education. Mean belief scores for necessity of taking diabetes medications were
higher for Caucasians (3.74) than for African Americans (3.49) (p0.0396) after ad-
justing for age, gender, education, time since diabetes diagnosis, number of med-
ications taken for diabetes and total medications taken for all conditions. Mean
scores for perceived harm from medications were higher for African Americans
(2.55) than Caucasians (2.29) (p0.0162). Mean scores for perceived overuse ofmed-
icines by prescribers were higher for African Americans (3.32) as compared to Cau-
casians (3.04) (p0.0497). CONCLUSIONS: Small differences in medication beliefs
between African Americans and Caucasians were observed after adjusting for
other covariates. Exploration of the role of medication beliefs in racial disparities
may be informative.
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OBJECTIVES: Individuals with diabetes type 2 usually show low compliance with
secondary prevention measures. Economic theory states that, from the demand
side, insurance reduces the incentives for individuals to claim self-protection and
hence, increases the ex-ante moral hazard while in the other hand, it selects indi-
viduals with lower risk preferences. This analysis aims to determine the net effect
of contributory and subsidized insurance on preventive effort in individuals un-
dergoing diabetes in Colombia. METHODS: Using data from the National Health
Survey-2007,we selected individuals aged between 18-69 andpreviously diagnosed
with diabetes (n  1446). We performed an instrumental variables model by treat-
ing the choice of insurance as endogenous and using self-employment and the
proportion of individuals insured under either contributory and subsidized regi-
mens in the municipality as instruments. In this analysis we present marginal
effects. RESULTS: We found evidence that, controlling for all covariates, health
insurance increases prevention care in individuals under the Contributory regimen
(0.259; SE 0,126) in comparison to uninsured individuals; however, for those en-
rolled in the Subsidized regimen the results were not significantly different when
comparing to uninsured individuals(0.047; SE 0.113). CONCLUSIONS: The internal-
ization of costs by health insurers throughout the life of individuals suffering from
diabetes is essential to improve secondary prevention in diabetes in the country. In
this case, we found that, unlike the Subsidized Regimen, the more comprehensive
benefits plan in the Contributory scheme is likely to increase the cost faced by the
insurer, encouraging it to promote preventive activities among individuals with
diabetes. This finding has important policy implications given the rapid growth in
health care costs to treat diabetes in Colombia. These results are easily inferred for
other preventable chronic conditions such as chronic obstructive pulmonary dis-
ease, heart disease and hypertension.
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OBJECTIVES: To review the variety of diabetes risk assessment tools and their
validity METHODS: An electronic literature search of the EMBASE, MEDLINE,
Cochrane library was undertaken using key words ‘diabetes risk’ and screening
or assessment or score or questionnaire, ‘diabetes prediction’, ‘medical screen-
ing’, and ‘health risk assessment’ from 1995-2010. References of identified arti-
cles were also manually searched. RESULTS: The electronic search retrieved a
total of 2168 articles reporting diabetes risk questionnaires. Deletion of duplicates
by Endnote andmanual culling produced a list of 41 questionnaires developed in 22
countries, with the majority (n26) developed in North America and Europe; the
remainder were from Asia (n10), Middle-East (n3), Africa (n1) and Austra-
lia(n1). Of the 41 questionnaires, 17 were developed for screening of undiagnosed
diabetes and 24 for predicting the risk of developing disease in the next 2-20 years.
All identified tools are short questionnaires of 2-16 questions with common vari-
ables of diabetes risk factor such as age, gender, waist circumference, BMI, family
history of diabetes, history of hypertension or antihypertensive medications being
used for risk assessment.While scoring format and cutoff points are diverse across
the questionnaires, the overall sensitivity, specificity, area under receiver operat-
ing characteristic curve (ROC) ranged from 40-97% and 24-86% and 62-87% respec-
tively. Comparatively speaking, there weremore tools developed for predicting the
risk of developing disease in recent years. CONCLUSIONS: There is a trend of
increasing availability of diabetes prediction tools with the existing diabetes risk
assessment tools being generally short questionnaire aiming for ease of use in
clinical practice. The overall performance of existing tools showed moderate to
high accuracy in their predictive performance. However, there are not enough
reports about their application in real-life clinical settings to allow an assessment
of their effectiveness in routine practice.
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OBJECTIVES: To identify patterns of antidiabetic drug prescribing in established
type 2 diabetes mellitus, to assess compliance of prescribing patterns with current
evidences and to describe determinants of the choice of antidiabetic drugs.
METHODS: Patients with established T2DM who attended the endocrinology Out-
patient Clinic in Postgraduate Institute of Medical Education and Research, Chan-
digarh, India were evaluated in a retrospective observational manner. Patients
were examined for social, demographical and clinical variables and medications.
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